0      0

2019 Nephrology Nursing Practice, Management, & Leadership Conference

212 - Sickle Cell Treatment Modalities: Apheresis and Hemodialysis


Oct 13, 2019 9:00am ‐ Oct 13, 2019 10:30am



Credits: None available.

Members: $30.00
Standard: $40.00

Description

This session provides an in-depth review of sickle cell disease, including genesis, pathophysiology, symptoms (and triggers), treatment options, as well as medical and nursing interventions.

Continuing Education Instructions and Disclosure Information

Contact hours available until 10/14/2021.

Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.

Faculty, Planners, and Speakers Conflict of Interest Disclosure:
Planning Committee:

Marijo Johnson - Employee, Fresenius Medical Care

There are no other disclosures to declare.

Commercial Support and Sponsorship:
No commercial support or sponsorship declared.

Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.

ANNA is a provider approved by the California Board of Registered Nursing, provider number CEP 00910.

Learning Outcome:
After completing this learning activity, the learner will outline a care plan for patients with sickle cell disease, including medical and nursing interventions.

Speaker(s):

  • Rasheed Balogun, MD, FACP, FASN, HP, Medical Director and Professor, University of Virginia Health System

Credits Available


You must be logged in and own this session in order to post comments.